Teva Pharmaceuticals Receive Warning Letter from FDA – Parker Waichman LLP
Teva, MedinCell receive FDA approval for Uzedy for schizophrenia
FDA warns eye drops may cause infection. Here's a list of 27 products to which the alert applies. - CBS News
FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com
TEVA Stock Pops 4% as Teva Receives FDA Approval | InvestorPlace
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva Recalls More Tainted Blood Pressure Drugs | BioSpace
FDA warns fake Adderall ADD medication being sold online
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
FDA Issues Warning About Fake Adderall | Fox 8 Cleveland WJW
Teva Set For Immediate US Launch Of Austedo In Tardive Dyskinesia :: Scrip
Celltrion FDA warning causes headache for Teva's biologics ambition
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Teva's troubled Godollo plant earns firm US FDA warning letter
Alvotech & Teva Bag FDA Approval for Humira Biosimilar, Simlandi | NAVLIN DAILY
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
ARS Pharma Shares Fall as FDA Declines to Approve Epinephrine Nasal Spray Neffy - WSJ
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma
FDA Warning Letters: May 2023 Edition
Warfarin Sodium by Teva Pharmaceuticals USA, Inc. WARFARIN SODIUM tablet
Teva Pharmaceuticals on X: "Today, the FDA approved an interchangeable #biosimilar that may provide broader access to needed medicines for patients with autoimmune diseases. Along with our partner @alvotechpr, we are proud
